Kevin Reeder, CEO of bm|t (one of neurocare´s largest investors) is a graduate in business administration with an MBA degree from the University of Oxford. Kevin has a long history in international investment management both in the US and in Europe and spanning venture capital, private equity, and publicly-traded investments. Prior to joining bm|t, Kevin worked for INVESCO, Silvergate Capital, GVO Asset Management, and Bank am Bellevue. His one professional engagement outside of the investment world was as Head of Data and Credit at M‑KOPA, a high-growth company in Africa, where he was responsible for the company´s fund raising and other financial activities as well as establishing M-KOPA´s data analysis platform. Kevin joined the neurocare board at the end of 2021 and sees his primary focus in fundraising, strategy, and M&A.